June 3, 2020: On February eleven, 2020, HHS issued a information (PDF, 162 KB) to state stakeholders holding antiviral drug products and solutions (Tamiflu and Relenza) about extra expiry courting extensions for properly held product or service. “…Based on FDA's assessment of scientific details, FDA has concluded for crisis responses https://felixzmyou.theblogfairy.com/32271954/facts-about-expired-listing-cards-revealed